FAQ
Frequently Asked Questions
Everything you might want to know, answered directly.
Who is Devangshu Mitra?+
I'm an AI Product Leader at HCLTech, where I build and ship 10+ GenAI products across Life Sciences & Healthcare — from drug discovery and clinical trial matching to adverse event detection and regulatory intelligence. I write about AI product craft, enterprise GenAI, and first-principles thinking.
What is The AI Product Brief?+
My newsletter covering weekly insights on building AI products in the enterprise. Written for PMs who ship, not consultants who advise. Free, no spam. Topics include product breakdowns, regulatory moves, frameworks, and tools.
How do I subscribe to the newsletter?+
Head to the Newsletter page and enter your email. It's free. No credit card. No spam.
How do I book a consulting session?+
All sessions are free. Head to the Consulting page and click 'Block Time on My Calendar' to book directly.
How do I invite you to speak?+
Head to the Speaking page for topics, bio, and booking link. I speak at conferences, podcasts, panels, and guest articles on enterprise AI, Life Sciences & Life Sciences & Healthcare AI, and product management.
Are the courses really free?+
Yes. All courses are free email courses. No pricing language, no paywalls. I share frameworks and knowledge as a practitioner — not as an instructor selling content.
How do I access the resources?+
Head to the Resources page. All resources are free Google Docs — view-only links, no sign-up required.
What industries do you cover?+
My deepest expertise is Life Sciences & Life Sciences & Healthcare AI — clinical trials, FDA regulatory, biopharma, medical devices. I also write about enterprise GenAI patterns that apply across healthcare, fintech, edtech, retail, and technology.
Can I republish or cite your writing?+
Yes, with attribution. Link back to the original post. For longer excerpts or commercial use, drop me a note via the consulting booking link.
How often do you publish?+
Articles go up several times a month. The newsletter is weekly. The Innovation Radar is updated as significant signals emerge — not on a fixed schedule.